The terms of the agreement are confidential, Credo said. The two companies also agreed to resolve Marvell’s pending challenges to Credo’s patents before the U.S. Patent and Trademark Office.
Credo shares had already gained 2.7% during the regular session, closing at $123.95.

Comments (0)
No comments yet. Be the first!